Capybara Research Goes Short On NUTX Stock, Alleges Fraudulent Business Practices
Capybara stated that more than a dozen Nutex partners, including physicians, medical directors, and board members, have accused Nutex and its CEO and Chairman, Thomas Vo, of wrongdoing, including fraud, embezzlement, and self-dealing.